Recurring thrombocytopenia associated with structured treatment interruption in patients with human immunodeficiency virus infection.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12942407.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a structured treatment interruption (STI) trial, 3 of 23 patients in a CD4 cell count-guided treatment arm developed recurring thrombocytopenia associated with the interruption of antiretroviral therapy. All 3 patients had slightly low or normal platelet counts before initiating antiretroviral therapy. STI may play a role in inducing thrombocytopenia in patients with human immunodeficiency virus infection.
Medical subject headings
- HIV Infections
- Thrombocytopenia